Waldenstroms

2019 WMFC Educational Forum Presentation – Dr. Castillo

Dr. Jorge Castillo – Associate Professor of Medicine, Harvard University – presenting “Treatment around the corner for Waldenstroms Macroglobulinemia” at the 2019 WMFC Educational Forum Toronto – April 2019

2019 WMFC Educational Forum Presentation – Dr. Chen

Dr. Christine Chen from the Princess Margaret Cancer Centre presenting on ” Navigating Treatment Options for Waldenstrom’s Macroglobulinemia in Canada” at the 2019 WMFC Educational Forum Toronto – April 2019

2019 WMFC Educational Forum Presentation – Dr. Ansell

Dr. Stephen Ansell, Professor of Medicine, Mayo Clinic
Presenting: Immunotherapy – Getting the immune system to target WM cells

2019 WMFC Educational Forum Presentation – Dr. Treon

Dr. Steven Treon – Bing Center for Waldenstroms Macroglobulinemia, Dana Farber Cancer Institute, Harvard Medical School

Presenting: Waldenstroms Macroglobulinemia: Genomic Based Treatment Advances

2019 WMFC Educational Forum Presentation – Dr. Matous

Dr. Jeffery Matous, Colorado Blood Cancer Institute
Presenting: Waldenstroms Macroglobulinemia: Basic Training for Patients

Video: First-Line Treatment for Waldenstroms Macroglobulinemia

Experts remark on goals of therapy and considerations for first-line therapy in patients with Waldenström macroglobulinemia.

Source: OncLive

Video: Approaching Newly Diagnosed Waldenstrom Macroglobulinemia

Insights From: Meletios A. Dimopoulos, MD, the National and Kapodistrian University of Athens School of Medicine; Steven P. Treon, MD, PhD, Dana-Farber Cancer Institute

Published: Friday, Mar 29, 2019

SOURCE: ONCLIVE – https://www.onclive.com/insights/treatment-updates-waldenstrom-macroglobulinemia/approaching-newly-diagnosed-waldenstrom-macroglobulinemia

News: Health Canada has approved the use of Ibutrinib/rituximab combination

In a press release issued March 8th it was announced that Health Canada has approved the use of Ibutrinib in combination with rituximab for both first and later lines of treatment for patients of Waldenstroms Macroglobulinemia.

The release has been… Continue reading →